Quality of life in Klinefelter patients on testosterone replacement therapy compared to healthy controls: an observational study on the impact of psychological distress, personality traits, and coping strategies.


Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
May 2021
Historique:
received: 11 06 2020
accepted: 18 08 2020
pubmed: 1 9 2020
medline: 16 11 2021
entrez: 1 9 2020
Statut: ppublish

Résumé

We aimed to verify if 1 year-testosterone-replacement therapy could produce a psychopathological recovery and a satisfactory quality of life in Klinefelter syndrome (KS) patients compared to matched healthy controls. Further, we analyzed personality traits and coping strategies, an issue not yet examined in androgen-treated KS patients. We also enquired whether any of the sociodemographic and psychological variables might predict a patient's general and sexual life satisfaction. The Quality of Life Enjoyment and Satisfaction Questionnaire and the Temperament and Character Inventory-Revised were administered to both 23 KS patients and matched healthy subjects. Psychopathology was investigated by the Symptom Checklist-90-Revised (SCL-90-R) and the Mini-mental State Examination. The COPE Inventory was used to identify cognitive and behavioral strategies to manage disease-related distress. In testosterone-treated KS patients, when compared with controls, SCL-90-R subscales analysis evidenced high psychological distress, mainly presented as obsessive thoughts, hanger-hostility, phobias, and psychoticism. Self-directedness and self-transcendence, along with the prevalent use of emotion-focused coping strategies, outlined the personality of our KS patients. Depression and somatization proved to be predictors of general life dissatisfaction. Depression, anger-hostility, and paranoid ideation, instead, emerged as predictors of sexual life dissatisfaction. Endocrinologists should cooperate with mental health providers to foster a better outcome of the disease in KS patients.

Identifiants

pubmed: 32865776
doi: 10.1007/s40618-020-01400-8
pii: 10.1007/s40618-020-01400-8
pmc: PMC8049912
doi:

Substances chimiques

Testosterone 3XMK78S47O

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1053-1063

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Sex Med. 2007 Jul;4(4 Pt 1):1056-69
pubmed: 17627750
J Endocrinol Invest. 2015 Jan;38(1):103-12
pubmed: 25384570
PLoS One. 2018 Nov 9;13(11):e0206932
pubmed: 30412595
Eur J Endocrinol. 2009 Mar;160(3):465-8
pubmed: 19131504
J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53
pubmed: 10946892
Endocr Rev. 2018 Aug 1;39(4):389-423
pubmed: 29438472
J Clin Endocrinol Metab. 2006 Apr;91(4):1423-7
pubmed: 16403821
Patient Educ Couns. 2013 Nov;93(2):248-54
pubmed: 23993396
Br J Psychiatry. 2006 Nov;189:459-60
pubmed: 17077438
J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010
pubmed: 16720669
Expert Rev Clin Pharmacol. 2018 Apr;11(4):439-458
pubmed: 29505313
Andrology. 2015 Sep;3(5):876-81
pubmed: 26216452
Arch Gen Psychiatry. 1987 Jun;44(6):573-88
pubmed: 3579504
Genet Med. 2011 Nov;13(11):966-72
pubmed: 21799429
World Psychiatry. 2006 Jun;5(2):71-6
pubmed: 16946938
Maturitas. 2002 Dec 10;43(4):231-7
pubmed: 12468130
J Pediatr. 2017 Jun;185:193-199.e4
pubmed: 28285751
Lancet. 2004 Jul 17-23;364(9430):273-83
pubmed: 15262106
World J Mens Health. 2013 Aug;31(2):103-25
pubmed: 24044106
Aging Male. 2003 Jun;6(2):86-93
pubmed: 12898792
J Endocrinol Invest. 2020 Dec;43(12):1675-1687
pubmed: 32567016
Genet Med. 2011 Jul;13(7):632-42
pubmed: 21546843
Endocr Pract. 1998 Jan-Feb;4(1):17-22
pubmed: 15251759
J Sex Med. 2018 Sep;15(9):1260-1271
pubmed: 30145097
Arch Gen Psychiatry. 1993 Dec;50(12):975-90
pubmed: 8250684
Schizophr Res. 2002 Mar 1;54(1-2):67-75
pubmed: 11853980
Am J Med Genet A. 2008 Mar 15;146A(6):708-19
pubmed: 18266239
Lancet. 2007 Sep 8;370(9590):859-77
pubmed: 17804063
J Endocrinol Invest. 2019 Jul;42(7):833-842
pubmed: 30499012
J Sex Med. 2015 Dec;12(12):2413-24
pubmed: 26612786
Psychopharmacol Bull. 1993;29(2):321-6
pubmed: 8290681
J Clin Endocrinol Metab. 1996 Oct;81(10):3654-62
pubmed: 8855818
Genet Med. 2018 Feb;20(2):214-222
pubmed: 28726803
Neurology. 2000 Jun 27;54(12):2218-23
pubmed: 10881243
J Endocrinol Invest. 2017 Feb;40(2):123-134
pubmed: 27644703
J Sex Med. 2013 Jun;10(6):1612-27
pubmed: 23551886
Asian J Androl. 2014 Mar-Apr;16(2):185-91
pubmed: 24407186
Clin Genet. 1988 Apr;33(4):262-9
pubmed: 3359683
Andrologia. 2006 Apr;38(2):48-53
pubmed: 16529575
Patient Educ Couns. 2015 Jan;98(1):90-5
pubmed: 25239793
Mayo Clin Proc. 2015 Aug;90(8):1104-15
pubmed: 26205546
J Health Soc Behav. 1980 Sep;21(3):219-39
pubmed: 7410799
J Clin Endocrinol Metab. 2005 Dec;90(12):6516-22
pubmed: 16204366
J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115
pubmed: 12534854
Dev Disabil Res Rev. 2009;15(4):284-94
pubmed: 20014369
Neuropsychologia. 2001;39(13):1385-94
pubmed: 11585606
Maturitas. 2005 Feb 14;50(2):124-33
pubmed: 15653010

Auteurs

M Fabrazzo (M)

Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Naples, Italy.

G Accardo (G)

Unit of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Science, University of Campania 'Luigi Vanvitelli', Naples, Italy.

I Abbondandolo (I)

Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Naples, Italy.

G Goglia (G)

Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Naples, Italy.

D Esposito (D)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

G Sampogna (G)

Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Naples, Italy.

F Catapano (F)

Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Naples, Italy.

D Giugliano (D)

Unit of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Science, University of Campania 'Luigi Vanvitelli', Naples, Italy.

D Pasquali (D)

Unit of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Science, University of Campania 'Luigi Vanvitelli', Naples, Italy. daniela.pasquali@unicampania.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH